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Introduction
The sorting of transmembrane receptors into multivesicular bodies
(MVBs) is a crucial feature of eukaryotic cell biology because of
its ability to regulate signal transduction. Since active signaling is
transduced via the cytoplasmic domain of the receptor, topologically,
signaling can still occur after internalization and delivery to early
endosomes. It is only after receptor sequestration into intralumenal
vesicles (ILVs) during MVB biogenesis that the signaling domain
is removed from the cytosol and signal transduction is arrested.
Sorting to MVBs is followed by fusion to lysosomes in which the
final degradation of receptors and other sorted cargoes now
embedded in ILVs occurs.
In yeast, genetic and biochemical evidence indicates that sorting
of cargoes to ILVs is regulated by monoubiquitylation and by the
function of the Hrs-STAM complex and three endosomal sorting
complexes required for transport (ESCRT-I, ESCRT-II, ESCRT-
III) (reviewed by Hurley and Emr, 2006). In this organism,
mutation of components of either the Hrs-STAM complex
(sometimes referred to as ESCRT-0) or the ESCRT-I, ESCRT-II,
ESCRT-III complexes leads to similar exclusion of cargoes from
the lumen of the vacuole, the yeast lysosome. These mutations
result in formation of an aberrant ‘class E’ endosomal compartment
characterized by extensive tubulation and absence of ILV-
containing MVBs, indicating that that Hrs-STAM and ESCRT
complexes are similarly required for MVB biogenesis (Raymond
et al., 1992; Vida et al., 1993; Rieder et al., 1996; Babst et al.,
2002; Bilodeau et al., 2002).
By contrast, in mammalian cells, studies using RNAi knockdown
have provided a less consistent picture of the functions of Hrs-STAM
and ESCRT-I, ESCRT-II, ESCRT-III in MVB biogenesis. In
mammalian cells depleted of Hrs, endosomes are enlarged, MVBs
are less abundant and contain a reduced number of internal vesicles
(Razi and Futter, 2006). In cells depleted of the ESCRT-I component
Tsg101, MVBs are not formed and are replaced by tubulated and
multilamellar structures reminiscent of the yeast class E
compartment (Doyotte et al., 2005; Razi and Futter, 2006); Finally,
in cells depleted of the ESCRT-III component Vps24, MVBs are
formed but they are smaller than those found in wild-type (WT)
cells (Bache et al., 2006).
Although little studied at the ultrastructural level, work in
Drosophila has shown that metazoan ESCRT activity can influence
an unexpected range of developmental processes (Lloyd et al., 2002;
Jekely and Rorth, 2003; Moberg et al., 2005; Thompson et al., 2005;
Vaccari and Bilder, 2005; Herz et al., 2006). For instance, the
ESCRT-I component Tsg101 and the ESCRT-II component Vps25
were found to act as neoplastic tumor suppressors (TSGs),
controlling both polarity and proliferation of epithelial cells. In
mutant cells, failure to degrade Notch and downregulate its signaling
ESCRT proteins were initially isolated in yeast as a single
functional set of conserved components controlling endosomal
cargo sorting and multivesicular body (MVB) biogenesis. Recent
work has suggested that metazoan ESCRT proteins might have
more functionally diverse roles, but the limited availability of
ESCRT mutants in species other than yeast has hampered a
thorough analysis. Here, we used a genetic screening strategy
based on both cell-autonomous and non-autonomous growth-
promotion phenotypes to isolate null mutations in nearly half
of the ESCRT-encoding genes of Drosophila, including
components of ESCRT-I, ESCRT-II and ESCRT-III complexes.
All ESCRT components are required for trafficking of
ubiquitylated proteins and are required to prevent excess Notch
and EGFR signaling. However, cells lacking certain ESCRT-III
components accumulate fewer ubiquitylated molecules in
endosomes and display reduced degrees of cell proliferation
compared with those lacking components of ESCRT-I and
ESCRT-II. Moreover, although we find by ultrastructural
analysis that MVB formation is impaired in ESCRT-I and
ESCRT-II mutant cells, MVB biogenesis still occurs to some
degree in ESCRT-III mutant cells. This work highlights the
multiple cell biological and developmental roles of ESCRT
proteins in Drosophila, suggests that the metazoan ESCRT-I,
ESCRT-II and ESCRT-III complexes do not serve identical
functions, and provides the basis for an extensive analysis of
metazoan ESCRT function.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/122/14/2413/DC1
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promotes proliferation non-autonomously. The cargoes associated
with Notch-independent phenotypes such as loss of cell polarity,
cell-autonomous enhancement of proliferation, and activation of
apoptosis have not been identified.
Whether these and other developmental functions in metazoans
require all ESCRT components remains an open question. For
example ESCRT-I, ESCRT-II and ESCRT-III components but not
Hrs are required to prevent ectopic Notch signaling activation in
Drosophila (Lloyd et al., 2002; Jekely and Rorth, 2003; Moberg
et al., 2005; Thompson et al., 2005; Vaccari and Bilder, 2005; Herz
et al., 2006; Vaccari et al., 2008). In addition, ESCRT-I and ESCRT-
III, but not ESCRT-II, appear to be required at the plasma
membrane for HIV virus budding and for the final step of
cytokinesis in mammals (Martin-Serrano et al., 2003; Morita et
al., 2007; Carlton et al., 2008). Finally, ESCRT proteins have also
acquired novel functions in metazoans that appear unrelated to their
role in protein degradation and MVB biogenesis. This is the case
for the regulation of anterior mRNA localization in Drosophila
oocytes, a function specific to ESCRT-II components (Irion and
St Johnston, 2007).
In summary, recent evidence indicates that metazoan ESCRT
proteins function in processes other than degradation of
ubiquitylated proteins and MVB biogenesis and that some of these
processes might be regulated by specific ESCRT complexes. Even
during protein degradation and MVB biogenesis, it is currently
unclear whether metazoan ESCRT complexes act as part of a single
pathway, as in they do in yeast. The study of the cell biological and
developmental role of ESCRT complexes in metazoans has, to date,
been hampered by the difficulty in analyzing tissues and cells
completely lacking function of each ESCRT component. Indeed,
ultrastructural and signaling analyses in mammals have relied mostly
on knockdown approaches, and in only a few cases have
developmental studies in Drosophila been conducted using null
mutants. Identification and comparative analysis of null mutants in
all of the ESCRT genes will be required for full elucidation of the
repertoire of metazoan ESCRT-regulated processes. Here, we report
the identification and initial comparative genetic, cell biological and
developmental characterization of null mutations in five novel
Drosophila ESCRT genes, belonging to the ESCRT-I, ESCRT-II
and ESCRT-III complexes. Our analyses highlight an additional cell
biological role of ESCRT proteins in Drosophila, and suggest that
the role of ESCRT-III in some ESCRT-mediated processes differs
from that of ESCRT-I and ESCRT-II.
Results
Efficient genetic screening identifies mutants that disrupt novel
ESCRT genes
To systematically isolate mutations disrupting Drosophila ESCRT
components, we first identified the homologs of each yeast ESCRT-
encoding gene in the fly genome. In yeast, the three ESCRT
complexes are composed of a total of eleven proteins. In Drosophila,
a single gene encoding homologs of each of these components exists,
with the exception of vps37 for which two homologs can be found.
Four ESCRT homologs map to chromosome arm 2R and 3R, two
to X and 3L and none to 2L (Table 1). Since chromosomes 2R and
3R contain the most predicted ESCRT genes, we devised a screening
strategy to isolate ESCRT mutations on these chromosome arms.
We exploited the fact that when larvae contain eye imaginal discs
that are completely composed of cells mutant for the ESCRT-I
component tsg101 or the ESCRT-II component vps25, a distinctive
‘giant larvae’ phenotype results (Moberg et al., 2005; Thompson et
al., 2005; Vaccari and Bilder, 2005). These animals are blocked in
pupation and do not eclose as adults; we refer to this phenotype as
‘mutant eyes, no eclosion’ (MENE) and have recently described an
efficient screen on chromosome 2L and 3R for MENE mutations
(Menut et al., 2007). We therefore used the same genetic strategy
to isolate MENE mutations on chromosome 2R to test whether
ESCRT mutations on this chromosome arm could be identified.
Statistics of the MENE mutations recovered in the 2R screen are
presented in Table 2.
ESCRT mutant tissue in Drosophila displays a cell-autonomous
loss of polarity and growth control (Moberg et al., 2005;
Thompson et al., 2005; Vaccari and Bilder, 2005). Such neoplastic
tumor suppressor gene (TSG) behavior results in the formation
of overgrown and disorganized imaginal discs that express high
levels of cortical actin and of matrix metalloprotease 1 (MMP-1)
(Menut et al., 2007). Thus, to identify putative ESCRT mutants
in our 2R MENE collection, we first immunostained mutant discs
to detect actin and MMP-1 (supplementary material Fig. S1; and
data not shown). We found that seven MENE mutants falling into
five complementation groups, named MENE(2R)A-E, displayed
a neoplastic tumor suppressor phenotype (supplementary material
Fig. S1C-H; Table 2). We have previously reported the
characterization of MENE(2R)D, which disrupts the ESCRT-II
component vps25 (Vaccari and Bilder, 2005). Not including
MENE(2R)D/vps25, together, the screen reported here and that of
Menut and colleagues (Menut et al,. 2007) establish a collection
Journal of Cell Science 122 (14)
Table 1. Conservation of ESCRT genes in Drosophila
Complex Yeast homologs Fly gene name CG number
Chromosome
arm Cytology Reference
Mvb12a – 7192 X 16F6 –
Vps23/Stp22 Erupted/tsg101 9172 3L 73D1 (Moberg et al., 2005)
Vps28 Dvps28 12770 2R 44A4 This study; (Sevrioukov et al., 2005)
vps37A/mod(r) 17828 X 1B12 –
ESCRT-I
Vps37
vps37B 1115 3R 82F6 –
Vps22 larsen/vps22 6637 3R 93F14 This study; (Irion and St Johnston, 2007)
Vps25 vps25 14750 2R 44D4 This study; (Thompson et al., 2005; Vaccari and Bilder,
2005; Herz et al., 2006)
ESCRT-II
Vps36 – 10711 3L 70B4 –
Vps2/Did4 – 14542 3R 96F10 This study
Vps20 – 4071 2R 58F2 This study
Vps24 – 9779 3R 82A4 –
ESCRT-III
Vps32/Snf7 shrub 8055 2R 45A12 This study; (Sweeney et al., 2006)
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2415Comparative ESCRT analysis in Drosophila
of mutations that disrupt 12 uncharacterized neoplastic TSGs on
chromosome 2R and 3R, possibly including novel ESCRT
components.
To identify mutations within this collection that might disrupt
genes encoding ESCRT proteins, we then tested the ability of the
newly identified mutations to affect non-autonomous growth, which
occurs in the ESCRT mutants tsg101 and vps25 but not other
identified neoplastic TSG mutants (Moberg et al., 2005; Thompson
et al., 2005; Vaccari and Bilder, 2005). Non-autonomous overgrowth
can be assessed by generating genetically mosaic eye discs
containing both WT and mutant cells, rather than discs composed
exclusively of mutant cells as was done in the MENE screen (Fig.
1). In these discs, cells mutant for non-ESCRT neoplastic TSGs,
such as avalanche (avl), were eliminated by cell competition (Fig.
1B). The resulting adult eyes were grossly morphologically normal
and contained all WT ommatidia (Fig. 1B!). By contrast,
complementation groups MENE(2R)-A to MENE(2R)-C,
MENE(3R)-A and MENE(3R)-E showed a distinct phenotype:
homozygous mutant tissue partially survived in the context of
mosaic eye discs (Fig. 1C-H); this phenotype was most pronounced
in MENE(2R)-A, MENE(2R)-B and MENE(3R)-A mutants. In
addition, although mutant ommatidia were not recovered in any of
Table 2. MENE (2R) screen
Statistics
Number of crosses Number of mutant chromosomes (estimated) Number of MENE alleles Initial hit (%)
10541 6662 98 1.5
Phenotypic classes
No defect Class Ia (hyperplastic)* Class Ib (nTSGs)† Class II (other)‡ Class III (small disc)§ Class IV¶
16 alleles 4 alleles 10 alleles 16 alleles 38 alleles 14 alleles
Class Ib mutants
Complementation group Number of alleles
MENE (2R)-A 3 (A2, B9, D2)
MENE (2R)-B 1 (I3)
MENE (2R)-C 2 (G5, O3)
MENE-D (vps25) 1 (A3)
MENE (2R)-E 1 (B6)
MENE (2R)-F 2 (C5, O9)
*See B15 in supplementary material Fig. S1.
†See MENE (2R) in supplementary material Fig. S1.
SSee I17 in supplementary material Fig. S1.
§See A16 in supplementary material Fig. S1.
¶Inconsistent defect or not determined.
Fig. 1. Neoplastic TSG complementation groups that control
proliferation non-autonomously. (A-H) Mosaic eye imaginal
discs stained with phalloidin to detect cortical filamentous actin
(F-actin; red). Mutant cells are marked by absence of GFP
expression (green). In contrast to avl clones (B), cells mutant for
ESCRT complementation groups MENE(2R)-A to MENE(2R)-D
and MENE(3R)-A, MENE(3R)-E (C-H) survive and
overproliferate to form disorganized masses of cells in the
context of mosaic discs (arrowheads in C). In addition, the WT
(GFP-positive) tissue surrounding ESCRT mutants
overproliferates to generate extra folds of tissue within enlarged
eye discs (arrows in C). Note that these phenotypes are less
pronounced in MENE(2R)-C/vps32/ESCRT-III (G) and
MENE(3R)-E/vps2/ESCRT-III (H). (A!-H!) Bright-field images
of adult eyes deriving from mosaic eye discs corresponding to
the same genotype as in A-H. Mutant chromosomes carry the
red pigment defective allele w–, whereas WT chromosome
carries w+. In contrast to control (A! arrowhead), ommatidia
composed of w– cells are not recovered, indicating that
homozygous neoplastic TSG mutant cells do not contribute to
the formation of adult eyes (B!-H!). Despite this, in contrast to
control (A!) and to the adult eye of avl mosaic animals (B!), the
adult eye of ESCRT mosaic animals is overgrown and bulging
(arrowhead in C!), revealing variable levels of non-autonomous
induction of proliferation (C!-H!). (I) Quantification of the adult
head width of the mosaic animals in A!-H! shows overgrowth in
ESCRT mutants compared with WT control (dashed line). Scale
bars: 100 µm.
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these genotypes, the WT ommatidia composing the adult eyes of
mosaic animals were variably overgrown (Fig. 1C!-H!). These data
indicate that, out of the collection of neoplastic TSG
complementation groups, five display an ESCRT-like behavior.
To test whether these five complementation groups disrupt ESCRT
loci, we performed complementation tests with chromosomal
deficiencies that remove genes encoding ESCRT proteins on the
appropriate chromosome arms. We found that all five
complementation groups failed to complement such deficiencies,
including those removing genes encoding the ESCRT-I component
Vps28, the ESCRT-II component Vps22, and the ESCRT-III
components Vps20, Vps32 and Vps2. Direct sequencing of the
ESCRT coding sequences in the 12 non-complementing alleles
revealed either nonsense mutations or deletions with one exception:
MENE(2R)-B contained an altered 3! mRNA splicing acceptor site
in intron 2 of vps20 (Table 3). All these mutations are predicted to
cause premature translation termination. Because all ESCRT proteins
are part of highly structured multicomponent complexes (Williams
and Urbé, 2007), even if expressed, the resulting predicted truncated
proteins are likely to disrupt formation of the corresponding complex.
The molecular data therefore predict that each of the novel ESCRT
mutants behaves as a functional null. Consistent with this assessment,
lethal-phase analysis of the ESCRT alleles on chromosome 2R
demonstrated that both animals homozygous for each mutant allele,
and animals hemizygous for a chromosomal deficiency removing the
locus, died as L1 larvae (data not shown).
We were surprised to isolate mutations in the ESCRT-I component
vps28 in the screen, since it has been reported that vps28 mutant
cells do not show cell polarity or proliferation phenotypes, nor do
they alter delivery of proteins to the lysosome or MVB formation
(Sevrioukov et al., 2005). In striking contrast, all three vps28 alleles
recovered in our screen caused neoplastic tumors (supplementary
material Fig. S1C; and data not shown). To confirm that the
phenotypes examined were due to loss of Vps28 function, we
performed a rescue experiment (supplementary material Fig. S2A-
B). We found that imaginal disc cells mutant for the neoplastic vps28
allele accumulated high amounts of ubiquitin (supplementary
material Fig. S2A), whereas transgenic expression of WT Vps28
in mutant cells rescued both the cell architecture and ubiquitin
degradation phenotypes (supplementary material Fig. S2B). These
data confirm that vps28 is indeed required for protein degradation
and neoplastic tumor suppression, and suggest that the previously
described vps28 allele is a partial loss-of-function mutant.
All newly identified Drosophila ESCRT components sort
ubiquitylated proteins and Notch
A major function of the yeast ESCRT proteins involves the
endosomal sorting and degradation of ubiquitylated proteins.
Mutations in Drosophila tsg101 (ESCRT-I) and vps25 (ESCRT-II)
lead to endosomal ubiquitin accumulation; we therefore tested
whether the additional Drosophila ESCRT proteins identified in the
screen are required for trafficking and degradation of ubiquitylated
cargo (Moberg et al., 2005; Thompson et al., 2005; Vaccari and
Bilder, 2005; Herz et al., 2006). We generated mosaic eye discs
containing clones of mutant cells for vps28 (ESCRT-I), vps22
(ESCRT-II), vps20, vps32 and vps2 (ESCRT-III) and immunostained
them to detect ubiquitin. We found that, in contrast to the WT, in
which no ubiquitin signal was detected because of the high rate of
degradation of ubiquitylated cargo, all ESCRT mutants tested
displayed severe intracellular ubiquitin accumulation (Fig. 2A-F).
These data demonstrate that all three Drosophila ESCRT complexes
are required for degradation of ubiquitylated proteins.
In addition to accumulating ubiquitylated proteins, tissue
mutant for the ESCRT-I, ESCRT-II and ESCRT-III components
Journal of Cell Science 122 (14)
Table 3. Sequencing of ESCRT mutations
Comp. Group Gene Complex Allele Mutation Amino acid change
A2  111 bp deletion
...GAGTTGAGCGAG
E186/211 r frameshift
B9 16 bp deletion
...CGACTGCATTAC
I49/211 r frameshift
MENE (2R)-A vps28 ESCRT-I
D2 nonsense
CGA r TGA
R102/211 r STOP
MENE (2R)-D vps25 ESCRT-II A3 (Vaccari and Bilder, 2005) –
NN31 nonsense
CAG r TAG
Q137/254 r STOP
SS6 nonsense
AAG r TAG
K218/254 r STOP
XX3 nonsense
TGG r TGA
W238/254 r STOP
MENE (3R)-A
   (Menut et al., 2007)
vps22 ESCRT-II
ZZ13 nonsense
TGG r TGA
W86/254 r STOP
MENE (2R)-B vps20 ESCRT-III I3 3! splice nonsense
TAG r TTG
K61/212 r frameshift
G5 384 bp deletion
...AGAAAAAGAAGC
K69/226 r frameshiftMENE (2R)-C vps32 ESCRT-III
O3 85 bp deletion
...CGATGCCATTTC
I145/226 r frameshift
MENE (3R)-E
   (Menut et al., 2007)
vps2 ESCRT-III PP6 nonsense
CAG r TAG
Q111/256 r STOP
For mutants containing point mutations, the mutated base is underlined. For mutants containing deletions, the nucleotide (nt) size of the deletion and the last
12 bases before the 5  breakpoint are displayed. The last amino acid before the introduced stop codon or frame shift relative to the total size is displayed in the
‘amino acid change’ column. Based on the published structure of the ESCRT-I and II complexes (reviewed by Saksena et al., 2007), Vps28 truncations are
predicted to lack part of the C-term domain that mediates recruitment of the ESCRT-II complex. For details about vps25 see Vaccari and Bilder (Vaccari and
Bilder, 2005). Vps22 truncations lack either Vps25 or Vps36 binding domains.
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2417Comparative ESCRT analysis in Drosophila
tsg101, vps25 or vps20 fails to degrade the signaling receptor
Notch (Moberg et al., 2005; Thompson et al., 2005; Vaccari and
Bilder, 2005; Herz et al., 2006; Vaccari et al., 2008). In mutant
cells, undegraded Notch accumulates in enlarged endosomes that
can be labeled by immunostaining for the endosomal syntaxin Avl
(Vaccari and Bilder, 2005). Thus, we assessed whether Notch
accumulates in enlarged endosomes in cells lacking Vps28
(ESCRT-I), Vps22 (ESCRT-II), Vps32 or Vps2 (ESCRT-III). All
mutants except for one showed a similar accumulation of Notch
in enlarged Avl-positive endosomes (Fig. 3A-F). Interestingly,
cells mutant for vps32 displayed lower amounts of accumulated
Notch than cells mutant for other ESCRT components (Fig. 3F).
We conducted a more extensive analysis of Notch accumulation
in vps32 mutant tissue, using antibodies directed to its extracellular
domain on both fixed and cultured live tissue. In both cases, Notch
accumulation was much less prominent in endosomes of vps32
mutants than in vps25 mutants, and in vps32 mutants, a subset of
Notch appeared to be redistributed to the cell cortex (Fig. 3G,L).
These data point to a different role for vps32 in Notch trafficking,
and suggest that in vps32 mutants either less Notch is internalized
and fails to be degraded, or that some Notch can escape endosomal
trapping.
Intracellular Notch accumulation in tsg101 and vps25 mutants
correlates with ectopic Notch signaling activation (Moberg et al.,
2005; Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et al.,
2006; Vaccari et al., 2008). Consistently, all ESCRT protein mutants
tested displayed ectopic expression of Unpaired, a specific Notch
target (Fig. 3M-R), although vps32 cells show lower amounts of
ectopic Unpaired. In addition, all ESCRT mutants tested also
ectopically express mβ-lacZ, a reporter for Notch signaling activity
(data not shown). These data indicate that ESCRT-I, ESCRT-II,
ESCRT-III components are required to control Notch signaling
activation, also reflected by their ability to promote non-autonomous
proliferation (Fig. 1).
All newly identified Drosophila ESCRT components
downregulate EGFR, restraining its signaling potential
Mammalian cell studies have shown that degradation of the
epidermal growth factor receptor (EGFR) is impaired when
ESCRT function is reduced via RNAi (Kanazawa et al., 2003;
Doyotte et al., 2005; Komada and Kitamura, 2005; Razi and
Futter, 2006). EGFR accumulation leads to sustained levels of
signaling activation in cells depleted of ESCRT-I and ESCRT-II
components, but interestingly, not ESCRT-III components (Babst
et al., 2000; Bache et al., 2006). In Drosophila embryos mutant
for hrs, EGFR degradation was also reduced and signaling was
enhanced (Lloyd et al., 2002), but the role of Drosophila ESCRT
components in regulating EGFR has not been assessed. To
examine how complete lack of ESCRT-I, ESCRT-II or ESCRT-
III function affects EGFR degradation in Drosophila, we stained
mosaic eye discs containing ESCRT mutant cells using an
antibody against EGFR. In eye discs containing ESCRT mutant
cells, some EGFR can be detected in intracellular puncta (Fig.
4A-E). These puncta also contain Notch, indicating that both
receptors accumulate in the same endosomal compartment and
suggesting that EGFR degradation is reduced in flies mutant for
ESCRT-I, ESCRT-II and ESCRT-III proteins.
To determine whether lack of ESCRT components alters EGFR
signaling, we stained mosaic eye discs containing ESCRT mutant
cells using an antibody against the EGFR signaling component
capicua (cic), whose nuclear expression levels are downregulated
upon EGFR signaling activation (Tseng et al., 2007). We found that
mutant cells showed lower nuclear Cic expression than surrounding
WT cells, indicating that ESCRT activity is required to downregulate
EGFR signaling (Fig. 4F-J). In addition, we assessed genetic
interactions between ESCRT and EGFR pathway mutants, using
ElpB1, a hypermorphic EGFR allele in which signaling
overactivation induces formation of ectopic wing veins (Baker and
Rubin, 1989). Consistent with the Cic data, we found that the ElpB1
oversignaling phenotype is dominantly enhanced by ESCRT null
alleles. It is also dominantly enhanced by mutants of the endosomal
syntaxin avl, which regulates endosomal cargo entry (Fig. 4K-M).
Overall, these data indicate that endocytosis, including MVB
sorting by ESCRT-I, ESCRT-II and ESCRT-III complexes, is
required for EGFR signaling downregulation in Drosophila.
ESCRT components are required for membrane stability and
actin cytoskeleton stability in Drosophila
Recent evidence points to the possibility that ESCRT functions
might have expanded to assume novel roles during metazoan
development. To analyze roles of ESCRT during Drosophila
oogenesis, we generated ESCRT-I, ESCRT-II and ESCRT-III null
germline clones. We confirmed that null alleles of ESCRT-II
(vps25) but not ESCRT–I (vps28) components show
mislocalization of Staufen to the anterior oocyte pole, a germline
ESCRT-II specific function independent of MVB sorting and
biogenesis (supplementary material Fig. S2C-F) (Irion and St
Johnston, 2007). These experiments showed that germline cells
mutant for components of ESCRT complexes developed to late
stages of oogenesis, indicating that ESCRT function is not
essential for overall oocyte development (Fig. 5D). However,
phalloidin staining revealed that ESCRT mutant germline cells
frequently lacked subcortical actin, suggesting the presence of
actin cytoskeleton defects (Fig. 5B,E-F,L). Similarly to the
germline, vps22 mutant follicle cells often appeared to lack
subcortical actin (Fig. 5F-G). We then generated clones of tsg101
Fig. 2. ESCRT complexes are required for degradation of ubiquitylated
proteins. ESCRT-I (A), ESCRT-II (B,C) and ESCRT-III (D-F) mosaic eye
discs stained with anti-ubiquitin. Compared with the WT tissue, ubiquitin
accumulates in intracellular puncta in clones of mutant cells, indicating failure
of degradative MVB sorting. Clones are encircled with dashed pink lines and
marked with an asterisk. Scale bar: 10 µm.
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(ESCRT-I) mutant cells in eye imaginal discs and again detected
defects in cortical actin cytoskeleton (Fig. 5H). To assess whether
the lack of cortical cytoskeleton reflected plasma membrane
defects that result in formation of multinucleated cells, we
subjected cultured mutant egg chambers to incorporation of FM4-
64, a lipophilic fluorescent dye. The absence of FM4-64
incorporation in many germline nuclei and the presence of
fragmented membranes suggests a loss of plasma membrane
integrity in ESCRT mutant cells (Fig. 5J). This ultimately led to
the formation of clusters of multinucleated cells enclosed by a
single actin cytoskeleton, whose nuclei rested around clumps of
actin-positive structures, possibly also membrane fragments (Fig.
5L). Together, these data suggest that ESCRT-I, ESCRT-II and
ESCRT-III function might be required for plasma membrane
integrity and stability of the actin cytoskeleton.
Drosophila ESCRT-I and ESCRT-II, but not hrs or ESCRT-III
components are required for MVB biogenesis
The isolation of null mutants in members of all three ESCRT
complexes gave us the opportunity to directly assess the role of
ESCRT proteins in metazoan MVB formation. In yeast, mutations
in components of the ESCRT-I and ESCRT-III complexes, as well
as in the hrs homolog, lead to a failure of MVB biogenesis, as
assessed by absence of endosomes containing ILVs in ultrastructural
analyses (Rieder et al., 1996; Babst et al., 2002; Bilodeau et al.,
2002). By contrast, mammalian studies utilizing RNA knockdown
concluded that although both Hrs and ESCRT-I proteins are required
for MVB formation, ESCRT-III components are dispensable (Bache
et al., 2003; Doyotte et al., 2005; Bache et al., 2006; Razi and Futter,
2006). To further investigate these differing findings in Drosophila,
we utilized null mutants for hrs (Hrs-STAM), tsg101 (ESCRT-I),
Journal of Cell Science 122 (14)
Fig. 3. Notch accumulates in endosomes of ESCRT mutant cells leading to overactivation of signaling. (A-F) ESCRT-I, ESCRT-II and ESCRT-III mosaic eye discs
stained with an antibody recognizing the intracellular domain of Notch. Compared with WT tissue, Notch is depleted from the cellular surface and accumulates in
enlarged endosomes (labeled Avl in A!-F!) in all ESCRT mutants except vp32 mutants, in which less Notch accumulates (F). (G-L) Notch localizes in intracellular
puncta in vps25 mutants and is diffuse in vps32 mutants. Notch immunodetection (Notch ECD; G-I) and 5 hour Notch internalization assay (inter. NECD; J-L)
using antibodies directed to the extracellular portion of Notch in WT (G,J), vps25 (H,K) and vps32 (I,L) entirely mutant eye disc tissue. In vps32 mutants, Notch
accumulation in intracellular puncta is reduced, whereas cortical localization is increased compared with vps25 (especially visible on fixed tissue in I). Note that in
J, very little signal is present because most Notch is degraded 5 hours after labeling. (M-R) ESCRT-I, ESCRT-II and ESCRT-III mosaic eye discs stained with an
antibody to detect expression of the Notch target unpaired (Upd). Compared with WT tissue, Upd is ectopically expressed to varying degrees in mutant cells.
Notably vps32 mutants appear to express the lowest amounts of Upd. Mutant tissue is encircled by dashed pink lines in A-F, M-R (white in A!-F!). Scale bars:
10 µm.
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2419Comparative ESCRT analysis in Drosophila
vps22 (ESCRT-II), and vps20 and vps32 (ESCRT-III) and tested
whether ESCRT function is required for MVB formation in
Drosophila. To this end, we analyzed endocytic compartments at
the ultrastructural level in mutant oocytes, prepared by making
germline clones (Fig. 6). Oocytes contain specialized endocytic
compartments, called yolk granules, that mediate uptake of yolk
proteins during vitellogenesis. During this process, most isolated
MVBs fuse with yolk-containing endosomes to generate yolk
granules that display a characteristic cortical population of ILV (Fig.
6A,B,H) (Schonbaum et al., 2000; Trougakos et al., 2001).
To identify the endocytic compartment and to follow yolk
granule formation, we immunolabeled yolk proteins in
ultrastructural preparations. In all mutant samples, labeling of yolk
protein is still observed, indicating that yolk protein internalization,
as expected, is not blocked in ESCRT mutants (Fig. 6C-G). We did
not observe endosome tubulation, which is typical of yeast class E
compartments, in any of the mutants. In oocytes mutant for hrs,
yolk granules containing ILVs and isolated MVBs are present,
although they are less abundant than in the WT; additionally,
internalized yolk proteins are detected in regularly shaped yolk
granules (Fig. 6C,H). This ultrastructural phenotype is consistent
with a previous analysis of hrs mutant Garland cells (Lloyd et al.,
2002), indicating that the endocytic phenotype observed in oocytes
is not unusual or tissue-specific. However, in sharp contrast with
hrs, in both tsg101 (ESCRT-I) and vps22 (ESCRT-II) mutant
oocytes, yolk granules that contain ILVs and isolated MVBs are
extremely rare (Fig. 6D,E,H). In addition to the near absence of all
ILVs, tsg101 and vps22 oocytes also show irregularly shaped yolk
granules (Fig. 6D-E). Remarkably, oocytes mutant for the ESCRT-
III genes vps32 or vps20 appeared phenotypically more similar to
those mutant for hrs than to tsg101 or vps22 mutants. Isolated MVBs
and yolk granules containing ILVs could be detected in vps32 and
vps20 mutant oocytes at frequencies that were similar to that of hrs
mutants, and the yolk granules were regularly shaped (Fig. 6F,G,
H). Together, these data suggest that MVB formation is not
completely impaired in cells lacking at least two of the four ESCRT-
Fig. 4. EGFR accumulation and EGFR signaling is overactivated in ESCRT mutants. (A-E!) ESCRT-I, ESCRT-II and ESCRT-III mosaic eye discs stained with
anti-EGFR (A-E) and Notch (merged in A!-E!); Compared with WT tissue, in mutant tissue (delimited by pink dashed lines) EGFR accumulation is seen in
intracellular puncta (examples are encircled in A-E) that are Notch positive. Note that compared with Notch, the majority of EGFR is still detected in other cellular
areas (arrowheads in B-C,E). (F-J) ESCRT-I, ESCRT-II and ESCRT-III mosaic eye discs stained with an antibody to detect expression of Capicua (Cic), a nuclear
negative regulator of EGFR signaling. Compared with WT tissue, Cic expression is reduced in ESCRT mutant cells (delimited by pink dashed lines), indicating
higher levels of EGFR signaling activation. Adult wings carrying Ellipse mutations, an activated form of EGFR (Elp; K). Animals also heterozygous for avl (Elp
avl; L) or vps2 (Elp vps2; M) show extra wing vein material, indicative of excessive EGFR signaling (arrowhead in K). The frequency of extra veins is increased in
Elp avl wings (+82% n=60; arrows in L) and, to a lesser extent in Elp vps2 (+38% n=19; arrows in L-M), indicating that excess EGFR signaling is enhanced by
reducing endocytic gene dosage. Scale bars: 10 µm (A-J), 100 µm (K-M).
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III components and indicate that in Drosophila, only ESCRT-I and
ESCRT-II complexes are absolutely required for MVB formation.
Discussion
Current models of ESCRT function draw heavily from studies in yeast,
where the complexes were first discovered and where they have been
most completely analyzed. However, the straightforward paradigm
from yeast – in which each component of the Hrs-STAM and ESCRT-
I, ESCRT-II, ESCRT-III complexes acts primarily in MVB sorting
and biogenesis – has been recently challenged by evidence in
metazoans pointing to more diversified roles. Studies of metazoan
tissues lacking each ESCRT component will be required to determine:
(1) differences in ESCRT function between yeast and metazoans, (2)
whether complexes and components always act together in a given
cellular process, and (3) the complete set of processes that ESCRT
genes regulate. Towards this goal we present here an efficient
screening method to identify ESCRT mutations in Drosophila. The
screen is based on the ability of ESCRT complexes to control tissue
growth both autonomously and non-autonomously. Screening of three
chromosome arms corresponding to approximately 60% of the
Drosophila genome led to the identification of null alleles of five
uncharacterized ESCRT genes, encoding components of all three
ESCRT complexes. Our screen recovered alleles of all but two of
the ESCRT homologs present on the chromosome arms screened.
Mutations in the vps24 homolog (ESCRT-III; CG9779) could not be
recovered with the mosaic strategy used, because it lies proximal to
the FRT used for screening. As for the second, CG1115 (ESCRT-I)
is one of the two vps37 homologs present in the Drosophila genome;
functional redundancy might mean that its inactivation alone does
not induce overgrowth. We predict that execution of this screening
strategy on chromosome arms X and 3L will further allow efficient
identification of three of the remaining five ESCRT genes.
It is notable that the screen recovered no mutations in the
Drosophila hrs or stam homologs, despite the fact that both genes
lie on chromosome 2L distal to the FRT site with which we screened
(Menut et al., 2007). In yeast, the Hrs-Stam complex has sometimes
been referred to as ‘ESCRT-0’ because both hrs and stam mutants
show identical disruption of trafficking and of endocytic
compartmentalization to that of ESCRT-I, ESCRT-II or ESCRT-III
mutants (Raymond et al., 1992; Bilodeu et al., 2002). However,
existing Drosophila hrs mutants do not affect epithelial polarity,
proliferation, or Notch signaling and ultrastructural data show
distinct cell biological phenotypes for hrs and the ESCRT-I, ESCRT-
II and ESCRT-III mutants analyzed in this work (Fig. 6) (Lloyd et
al., 2002; Jekely and Rorth, 2003). Furthermore, mammalian RNA
knockdown studies are consistent with different functions for the
Hrs-Stam and ESCRT-I complexes (Sun et al., 2003; Razi and Futter,
2006). It is possible that functional redundancy between hrs and
stam could explain the phenotypic difference between Drosophila
hrs and ESCRT mutants, although we are not aware of any reports
of redundant functions in the literature. An intriguing alternative
possibility is that other proteins, perhaps the ESCRT-I complex,
might functionally substitute for the metazoan Hrs-STAM complex.
In agreement with this possibility, HIV-1 budding, a process
topologically equivalent to ILV formation, is carried out by ESCRT-
I and ESCRT-III components in the absence of Hrs-STAM function
(Martin-Serrano et al., 2003); functional overlap might also be
suggested by an earlier evolutionary origin for ESCRT complexes
(Leung et al., 2008). A third possibility is that the Hrs-STAM
complex acts in receptor protein degradation, but at a different step
than other ESCRT complexes, one that is less crucial to control
epithelial organization and Notch signaling. In either case, our results
using null mutants in Drosophila highlight an important distinction
between the function of ESCRTs and other ubiquitin-binding
protein complexes in yeast and metazoans.
If ESCRT complexes do have a different role to the Hrs-STAM
complex, how often do all three ESCRT complexes act together in
a given cellular process? The identification of mutants in many
Journal of Cell Science 122 (14)
Fig. 5. ESCRT complexes regulate actin cytoskeleton stability and membrane integrity. (A-E) Stage 6 (A,C,E) and stage 10 (B,D) egg chambers stained with
phalloidin to reveal the cortical actin cytoskeleton. Compared with WT (A,B), egg chambers containing vps28 (ESCRT-I) and vps25 (ESCRT-II) mutant germline
cells (C-E) display varying degree of loss of cortical actin cytoskeleton (arrowhead in C-D). (F,G) Germarium and stage 1 egg chamber (F) and follicle cells
overlaying a stage 9 egg chamber mutant for the ESCRT-II component vps22 (delimited by the pink dashed line) display similar F-actin defects. (H) Eye imaginal
disc cells mutant for the ESCRT-I component tsg101 (delimited by the pink dashed line) display increased F-actin staining compared with surrounding WT cells.
Despite this, loss of cortical actin cytoskeleton is observed, leading to clusters of two nuclei surrounded by a single actin cytoskeleton (arrowheads in H). In F-H
cells are counterstained with Topro3 to visualize the nuclei. (I-L) Stage 6 egg chambers containing WT (I, K) or vps2 (ESCRT-II) (J,L) mutant germline cells
treated with FM4-64, a lipophylic dye that fluoresces upon membrane incorporation (I-J) or stained to detect F-actin and the nuclear membrane (WGA) (K,L). The
plasma membrane dividing mutant cells appears incomplete (arrowhead in J), leading to the formation of multinucleated cells (arrowhead in L). Scale bars: 10 µm
(A,C,E-L), 50 µm (B,D).
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2421Comparative ESCRT analysis in Drosophila
uncharacterized ESCRT genes provides a chance to explore this
question by comparing the functions of the individual components
and complexes. In most of the in vivo cellular and developmental
assays we used, the ESCRT mutants closely resemble one another:
they all cause autonomous neoplastic transformation, non-
autonomous overproliferation (albeit to varying degrees), trap
ubiquitylated proteins, and control stability of the actin cytoskeleton
and membrane integrity. These data indicate that, as in yeast,
Drosophila ESCRT complexes work together as a single functional
unit to regulate these processes.
The existence of process-specific roles for individual ESCRT
complexes in mammalian cells has been inferred by RNAi, which
causes only a partial depletion of gene product. For instance,
depletion of several ESCRT-I and ESCRT-II components but not the
ESCRT-III component vps24 by RNAi impairs EGFR degradation
and signaling (Bache et al., 2006). This contrasts with our results
using null alleles, which suggest that control of EGFR signaling is
not a function where ESCRT components have different roles. Indeed,
our data indicate a partial failure to degrade EGFR and upregulation
of EGFR signaling in mutants for all of the ESCRT-III components
examined. We have not yet analyzed vps24 mutant cells (owing to
its cytological location, as mentioned above), and it cannot be ruled
out that functions of fly and mammalian ESCRT-III in EGFR
degradation might differ. However, our analysis of vps28 illustrates
the importance of distinguishing null and hypomorphic situations.
The previously studied vps28 allele behaved as a strong hypomorph
in genetic tests and almost no protein product could be detected in
mutant tissue (Sevrioukov et al., 2005); the distinct trafficking,
ultrastructural and developmental phenotypes of this allele raised the
possibility that Vps28 had functions distinct from other ESCRT
components. However, our isolation and analysis of true molecular
null mutants reveals that the phenotype of vps28 is indeed identical
to other ESCRT-1 components, underlining the value of null alleles
in reaching definitive conclusions about ESCRT function.
Fig. 6. Ultrastructural characterization of ESCRT-mutants. ESCRT-I, ESCRT-II but not hrs or ESCRT-III are crucial for MVB biogenesis. (A-G) Yolk protein
immunolabeling with 10 nm gold particles on cryosections of Drosophila oocytes. WT stage 9-10 oocytes show accumulation of yolk proteins in the yolk granules
(A). Isolated MVBs containing ILVs are also frequently observed in the ooplasm (A!). Additionally ILV-containing yolk granules (ILVYGs), derived from fusion
with MVBs, are frequently observed (B). Magnification (B!) shows that ILVYGs contain ILVs. (C) In hrs (ESCRT-0) mutants, there is a similar phenotype, with
presence of isolated MVBs and ILVYGs, although they are less abundant than in WT oocytes (arrowhead in C! indicates ILV). (D) In the tsg101 (ESCRT-I)
mutants, the yolk granules still accumulate with large diameters; however, ILVYGs and isolated MVBs are absent. vps22 (ESCRT-II) mutant oocytes (E) also lack
ILVYGs and isolated MVBs. (D!-E!) Magnifications show lack of ILVs. Compared with WT, the tsg101 and vps22 yolk granules are irregularly shaped. (F,G) By
contrast, the vps32 and vps20 (ESCRT-III) mutant oocytes possess regularly shaped ILVYGs as well as isolated MVBs, which are more similar to hrs. Scale bars:
1 µm (A-G), 0.25 µm (A!-G!). (H) Quantification of the number of ILVYGs and MVBs per 100 µm2 in WT and mutant stage 10 ovaries. The number of ILVYGs
and MVBs formed in the ESCRT-III mutants analyzed is similar to that of hrs mutant. By contrast, ESCRT-I and ESCRT-II mutant oocytes contains almost no
ILVYGs and MVBs. Results are means ± s.d.
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Nevertheless, we have noted consistent differences amongst null
ESCRT component phenotypes, which interestingly all concern
ESCRT-III components. In one example, vps2 mosaic discs are less
overgrown than other ESCRT mutant discs, both because the mutant
clones are smaller and because less non-autonomous growth is present
compared with other ESCRT mutants. Similarly, vps32 clones grow
less than vps20 clones but, in this case, non-autonomous growth is
as strong as in vps20 mosaic eyes. In addition, cells lacking the
ESCRT-III component Vps32 displayed less endosomal accumulation
of Notch and more plasma membrane localization than other ESCRT
mutants, suggesting that either Notch escapes endosomal trapping or
that Vps32 is also required for initial internalization. Differential
trapping of Notch might affect the extent of its ectopic activation.
Most unexpectedly, although oocytes mutant for ESCRT-I or
ESCRT-II components display almost no endocytic compartments
that contain ILVs, oocytes mutant for the ESCRT-III components
vps32 and vps20 still display ILV-containing endocytic structures,
albeit at a reduced frequency. This is in strong contrast to yeast,
where the best-characterized role of yeast ESCRT proteins is in the
formation of ILV-containing MVBs. Although we cannot absolutely
rule out differential effects on protein stability in our germline clones,
this would seem to be an unlikely explanation for the different
phenotypes we observe (see Materials and Methods). Instead, these
findings might suggest that the ESCRT-III complex acts slightly
differently than ESCRT-I and ESCRT-II in controlling protein
degradation and MVB biogenesis. Interestingly, two recent reports
find that Vps32 homologs form oligomeric filaments that might either
inwardly invaginate the endosomal membrane during MVB
biogenesis, retain cargoes within these invaginations, or perform both
functions (Hanson et al., 2008; Teis et al., 2008). The fact that at
least two Drosophila ESCRT-III components appear dispensable in
part for MVB formation, together with the reduced accumulation of
Notch and cell-autonomous and non-autonomous proliferation of
certain ESCRT-III mutants, when compared with ESCRT-II mutants,
indicate that in Drosophila, the ESCRT-III complex might be more
crucial for cargo retention than endomembrane invagination.
In the data discussed above we tested known or expected functions
of ESCRT proteins. However, the isolation of many ESCRT mutants
also provides the opportunity to search for novel functions, one of
which we describe here that is common to all the ESCRT genes.
Cells mutants for any ESCRT component show strong defects in
actin and plasma membrane organization. ESCRT complexes might
directly regulate the actin cytoskeleton, as previously suggested
(Sevrioukov et al., 2005). However, we also detected a failure to
incorporate lypophilic dyes into the plasma membranes of ESCRT
mutant cells. This suggests that the loss of cortical actin and loss of
plasma membrane might be related, ultimately leading to the
formation of multinucleated cells. Recent reports have demonstrated
that mammalian ESCRT components interact with midbody proteins
and control the last steps of cytokinesis, a process topologically
similar to HIV and exosome budding from the plasma membrane
and endomembrane invagination during MVB formation (Morita et
al., 2007; Carlton et al., 2008). This raises the possibility that
defective cytokinesis might account for the presence of
multinucleated cells in Drosophila ESCRT mutants. However, we
also observed these defects in cells lacking ESCRT-II components,
which are dispensable for cytokinesis in mammalian cells, suggesting
that the actin and plasma membrane organization might not be a
consequence of aberrant cytokinesis. In addition, knockdown of
several ESCRT components in Drosophila tissue culture cells does
not lead to high proportion of multinucleated cells (data not shown).
Interestingly, the germline phenotype of ESCRT mutants is
reminiscent of that reported for cells lacking the exocytic trafficking
proteins Sec5 and Rab6 and the recycling component Rab11 (Murthy
and Schwarz, 2004; Bogard et al., 2007; Coutelis and Ephrussi,
2007). Thus, we raise the possibility that ESCRT complexes might
also have a role in stabilizing the plasma membrane and its
underlying actin cytoskeleton during membrane growth after cell
division, a process particularly crucial during egg chamber
development. Future work will be required to evaluate this potentially
underappreciated role of ESCRT in membrane stabilization.
In conclusion, our identification and initial comparative genetic,
cell and developmental analysis of null mutants for nearly half of
the ESCRT genes encoded by the Drosophila genome refines the
current understanding of their role in degradation of ubiquitylated
proteins and MVB biogenesis. It also clarifies previous contrasting
evidence on ESCRT function in yeast, Drosophila and mammals.
Finally, it uncovers a novel developmentally relevant role for
ESCRT genes. Future use and expansion of the toolbox of
Drosophila null ESCRT mutants reported here will pave the way
to the elucidation of the full repertoire of metazoan-specific ESCRT-
dependent processes, and those that are common to all complexes
as well as those that are complex- or component-specific.
Materials and Methods
Genetics and fly stocks
EMS screening was conducted using isogenized stocks of w; FRT42. The MENE
screen on 2R utilized the line yw eyFLP; cl [w+] FRT42/CyO TwiGal4 UAS-GFP
(Newsome et al., 2000). Gla/CyO TwiGal4 UAS-GFP was used to balance and stock
mutant chromosomes. yw;; eyFLP cl GMR-hid FRT82/TM6C was used to generate
entirely mutant eye discs for 3R ESCRT mutants. To generate mosaic eyes we used
yw eyFLP; ubiGFP[w+] FRT42 and yw eyFLP; ubiGFP FRT82 (Tapon et al., 2001)
and for mosaic wing discs, UbxFLP; ubiGFP[w+] FRT42/Cyo (Hong et al., 2003).
We utilized hsFLP; armLacZ FRT42 (Bloomington), and hsFLP OvoD FRT40, 80
and 82 lines to generate germline clones (Chou et al., 1993). Other alleles utilized
were: tsg101/ept2, vps25A3, avl1, hrsD28 (Lloyd et al., 2002; Lu and Bilder, 2005;
Moberg et al., 2005; Vaccari and Bilder, 2005).
EMS mutagenesis
Male flies carrying an isogenized FRT chromosome were starved for 8 hours and
subsequently fed a 25 mM EMS solution overnight at room temperature. To screen
the 2R chromosome arm, mutagenized FRT42 males were mated en masse to Gla/CyO
TwiGal4 UAS-GFP females. Single F1 males of the genotype *FRT42/Cyo TwiGal4
UAS-GFP were each crossed to three females of the genotype eyFLP cl FRT42/CyO
TwiGal4 UAS-GFP. Absence of non-CyO adults in the F2 progeny indicated a positive
MENE phenotype. Mutant chromosomes were then recovered by crossing F2 males
of the genotype *FRT42/Cyo TwiGal4 UAS-GFP to Gla/Cyo TwiGal4 UAS-GFP
females.
Immunohistochemistry, FM4-64 incorporation and confocal
microscopy
Fixation was performed at room temperature for 20 minutes in a methanol-free, 4%
paraformaldehyde solution. Actin staining was done using TRITC-conjugated
phalloidin 1:500 (Sigma). Before antibody staining samples were incubated in a
blocking solution of 5% normal goat serum. Primary antibody stains were done at
4°C overnight, and secondary antibody stains were done at room temperature for 2
hours. Primary antibodies to the following antigen were used: Notch ICD, Notch
ECD (1:50; both from DSHB), Ubiquitin (FK2 1:1000; Biomol). Secondary antibodies
used were conjugated Alexa Fluor 488 and Alexa Fluor 647 from Molecular Probes.
Notch internalization was performed as described (Vaccari et al., 2008). For FM4-
64 (Molecular Probes) incorporation, ovaries were dissected in S2 cell medium
(Sigma) and incubated in medium containing 10 µM FM4-64 for 5 minutes at room
temperature, washed in fresh medium, mounted and imaged. All images are single
confocal sections taken with a TCS microscope (Leica) using 16" NA0.5, 40"
NA1.25 or 63" NA1.4 oil lenses. Images were edited with Adobe Photoshop CS
and were assembled with Adobe Illustrator 10.
Transmission electron microscopy
To minimize protein perdurance in germline clone analysis, we analyzed stage 10
oocytes from females at least 1 week old. Because the germline originates from a
single stem cell, the analyzed tissue corresponds approximately to at least 10 days
after gene inactivation and an expected 104 dilution of the original protein
Journal of Cell Science 122 (14)
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concentration because of increasing cytoplasmic volume (D.B. unpublished and Kevin
Kolahi and Anne K. Classen, University of California, Berkeley, CA, personal
communication). Dissected ovaries were immediately transferred to fixative containing
4% formaldehyde and 0.1% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Single
oocytes were embedded in 10% gelatin, infused with 2.3 M sucrose and frozen in
liquid nitrogen. Sections were cut at –11°C and picked up with a 1:1 mixture of 2.3
M sucrose and 2.0 M methyl cellulose. Sections were labeled with a rabbit antibody
against yolk protein (Trougakos et al., 2001), followed by 10 nm protein A gold, and
observed in a JEOL-1230 electron microscope at 60-80 kV. Images were recorded
with a Morada digital camera using iTEM (SIS) software.
Quantification of EM data
ESCRT mutant germlines prepared as above were labeled with Rat anti-yolk antibody
and the number of isolated MVBs and of ILV-containing yolk granules (ILVYGs) in
the oocyte were counted. Vesicles containing only ILVs without significant yolk
accumulation were scored as MVBs, whereas MVBs containing visible yolk
accumulations were scored as ILVYGs. Oocytes were scanned in a systematic random
fashion and the areas quantified were as follows: WT, 1360 µm2; hrs, 2500 µm2;
tsg101, 1583 µm2; vps32, 1060 µm2; vps22, 1940 µm2; vps20, 1360 µm2. Values are
the mean results from two to three different oocytes ± s.d.
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